Validity of the BPRS, the BDI and the BAI in dual diagnosis patients
|
|
- Imogen Gray
- 8 years ago
- Views:
Transcription
1 Available online at Addictive Behaviors 33 (2008) Validity of the BPRS, the BDI and the BAI in dual diagnosis patients Jørn Lykke a,, Morten Hesse b, Stephen Fitzgerald Austin a, Irene Oestrich a a St. Hans' Hospital, Boserupvej 2, 4000 Roskilde, Denmark b Center for Alcohol and Drug Research, Aarhus University, Købmagergade 26E, 1150 Copenhagen C, Denmark Abstract Aim: The psychometric properties of the Brief Psychiatric Rating Scale, the Beck Anxiety Inventory (BAI), and the Beck Depression Inventory (BDI) were tested in a sample of 134 patients with a substance use disorder and a nonsubstance related psychiatric disorder in a special inpatient dual diagnosis treatment unit. Methods: Subjects were assessed at baseline. At discharge on average 6 months post-intake, 78% of patients were re-assessed using the same instruments. All instruments were tested in (1) their ability to discriminate patients with different diagnoses at baseline and follow-up using comparison of area under the curves, and (2) their temporal stability. Moderator regression was used to test whether thought disorder at baseline had any effect on the test retest rank-order stability of other instruments. Findings: The BPRS Thought Disorder scale was able to discriminate between patients with and without schizophrenia spectrum diagnoses, and the BDI was able to discriminate between patients with and without mood disorders and schizoaffective disorders at intake to treatment, and each instrument was significantly better than the other at discriminating relevant diagnostic groups. Discriminant correlations between the BDI and the BAI were high and statistically significant. Moderator regression analyses showed no indication that any of the scales were less stable at higher levels of thought disorder. Conclusions: It is concluded that dual diagnosis patients can be reliably assessed for symptoms using the BDI and some subscales of the BPRS Elsevier Ltd. All rights reserved. Keywords: Psychopathology; Schizophrenia; Dual diagnosis; Diagnostic validity; Inpatient; BPRS; BDI; Depression; Substance abuse Corresponding author. address: Joern.Lykke@shh.regionh.dk (J. Lykke) /$ - see front matter 2007 Elsevier Ltd. All rights reserved. doi: /j.addbeh
2 J. Lykke et al. / Addictive Behaviors 33 (2008) Introduction Clinical and epidemiologic studies have shown a high co-occurrence of substance use disorders and other psychiatric disorders, with important consequences from health and social perspective, and for treatment. The aetiology of such co-morbidity is unclear, but the accumulation of multiple risk factors related to mental illness, including emotional instability, may increase the risk of substance use disorder (Mueser, Drake, & Wallach, 1998). Patients with schizophrenia (Krystal et al., 2006), depression (Grant et al., 2004), and some anxiety disorders (Grant et al., 2004) are at an increased risk of substance use disorders. Patients with psychotic illness and substance abuse are more difficult to retain in outpatient treatment than patients with psychotic illness alone (Fuciec, Mohr, & Garin, 2003), and more likely to be non-compliant with pharmacotherapy (Elbogen et al., 2005). However, the reliable and valid assessment of psychiatric problems in patients with substance abuse may be problematic, mainly because the acute or chronic effects of substance abuse can mimic symptoms of other mental disorders, making difficult to differentiate psychiatric symptoms that are effects of acute or chronic substance use or withdrawal, of those that represent an independent disorder. Therefore, it is necessary that assessment of psychiatric symptoms is conducted with scales that are validated with this population. In this report, we examine the concurrent validity of several instruments used to assess psychopathology in a sample of patients with substance dependence or abuse and serious co-morbid psychiatric symptoms. For instance, the acute stress associated with seeking treatment may temporarily exacerbate depressive symptoms (Elbogen et al., 2005); use of psycho-stimulants or hallucinogens may induce symptoms that are similar to symptoms of psychosis, and serious dependence on cannabis may produce a state of withdrawal that may appear similar to withdrawal in schizophrenia spectrum disorders (Schuckit, 2006). The Brief Psychiatric Rating Scale is a brief interviewer-administered instrument designed to assess the symptoms of schizophrenia (Overall & Gorham, 1988). Based on the BPRS, it is possible to estimate a full-scale score. Based on factor analyses, 5 subscales have been derived: Thought Disorder (TD), Withdrawal (W), Anxiety/Depression (AD), Hostility (H) and Activity (A) (Hedlund & Vieweg, 1980). The Thought Disorder factor is related to positive symptoms of schizophrenia (grandiosity, hallucinations, unusual thought content and conceptual disorganisation) the Withdrawal Factor is related to negative symptoms (disorientation, blunted affect, emotional withdrawal and motor retardation), the Anxiety Depression Factor (somatic concerns, anxiety, guilt and depression), the Hostility Factor (hostility, suspicion and uncooperativeness) and the Activity Factor (tension, excitement mannerisms and posturing). On the BPRS full scale, patients with schizophrenia scoring 32 or more are considered mildly ill, patients scoring 44 or more are considered moderately ill, patients scoring 52 are considered markedly ill, and patients scoring over 68 are considered severely ill (Leucht et al., 2005). The TD, W, H and A scales should differ from symptoms of depression or anxiety, and therefore should discriminate patients with schizophrenia from patients with non-schizophrenia spectrum disorder. Also, as the full-scale BPRS is believed to be a measure of the overall severity of schizophrenia, it should be able to discriminate patients with schizophrenia from patients without schizophrenia. Other subscales of the BPRS, such as the AD scale, should be higher, rather than lower, in patients with anxiety or depression, relative to patients with schizophrenia. The justification for this assertion was that although some patients with schizophrenia suffer from symptoms of anxiety or depression, patients with anxiety or depression diagnoses should have these symptoms consistently.
3 294 J. Lykke et al. / Addictive Behaviors 33 (2008) We expected patients with schizophrenia to function more poorly than patients with other disorders, due to the very serious adverse consequences of schizophrenia on the quality of life (Thornicroft et al., 2004). This was measured with the Global Assessment of Functioning scale (APA, 2000). The Beck Depression Inventory (BDI) is a 21-item self-report inventory designed to assess the severity of current depression (Beck, Steer, & Garbin, 1988), and the Beck Anxiety Inventory is a 21-item selfreport inventory designed to assess the severity of current anxiety (Steer & Ranieri, 1993). Both are instruments that have been extensively studied in both clinical and non-clinical samples. There is some indication that the Beck Depression Inventory is valid in substance abusers (Hesse, 2006). The Beck Anxiety Inventory is used somewhat less in research than the Beck Depression Inventory, but has been used in several studies of patients with substance abuse (Husband et al., 1996; Sumnall, Wagstaff, & Cole, 2004). However, to our knowledge, no study has assessed whether the Beck Depression Inventory can discriminate patients with co-morbid mood disorders and substance dependence from patients with substance dependence and other co-morbid psychiatric conditions, or whether the Beck Anxiety Inventory can discriminate patients with co-morbid anxiety disorders from patients with other comorbidities. Further, self-report inventories could potentially be problematic in patients with psychotic disorders. Patients with residual psychotic symptoms might be unable to fully understand or rate selfreport items. To our knowledge, no studies have assessed this question. 2. Methods 2.1. Setting The cohort studied were consecutive admissions to an inpatient psychiatric unit, Fjordhuset and the St. Hans Hospital in Roskilde, Denmark in the period from April 10th 2004 to February 2nd The unit is an inpatient treatment unit providing cognitive milieu therapy for patients with substance dependence and psychiatric illness. The unit is staffed with psychiatrists, psychologists, nurses and assistants, and is situated in Roskilde, close to Copenhagen. Patients are typically referred to the unit when they have a chronic substance dependence and psychiatric illness requiring extended inpatient treatment. In general patients who are acutely psychotic are first admitted to their local psychiatric inpatient unit and then referred to extended inpatient treatment at the unit, once they have been stabilised Inclusion and exclusion criteria Inclusion to the study required the presence of at least one diagnosis of substance use disorder (and ICD-10 (WHO, 1993) diagnosis of F10 F19.99), and at least one additional psychiatric diagnosis of schizophrenia spectrum or mood disorder (F20 F39.99). Participants should also be willing to participate in the treatment, be fluent in Danish, complete questionnaires, and give informed consent. Patients that had organic brain damage or were involuntarily admitted to the unit were excluded from the study Assessment Psychiatric diagnoses Subjects were assessed at admission to the unit by a psychiatrist. Diagnoses were made according to the International Classification of Diseases and coded in the patients' medical files (WHO, 1993). The unit
4 J. Lykke et al. / Addictive Behaviors 33 (2008) psychiatrists had access to the reports and files from previous admissions and/or contact with psychiatric services Self-report inventories Patients completed the Beck Depression Inventory (BDI) (Beck et al., 1988) and the Beck Anxiety Inventory (BAI) (Beck & Steer, 1991) Psychiatric rating scales Patients were rated with the Brief Psychiatric Rating Scale (BPRS) (Overall & Gorham, 1988) by independent psychiatrists at baseline and follow-up. Prior to assessment of patients, each of the psychiatrists conducting the BPRS ratings received training in the rating, and rated a video of a patient. These psychiatrists were not involved in the diagnosis or treatment of patients. The BPRS is a psychiatric rating scale that is completed during an interview with the patient. Additionally, patients were rated using the Global Assessment of Functioning (GAF) scale (APA, 2000). The Global Assessment of Functioning was rated using the split version, with both a symptom and a functioning component (Pedersen, Hagtvet, & Karterud, 2007) Hypotheses The following hypotheses were stated: Patients with schizophrenia spectrum diagnoses (F20 F29.99) were expected to score higher on the BPRS full scale, the Thought Disorder scale, the Hostility scale, and the Activity scale. While all subscales of the BPRS are used to assess schizophrenics, we deemed it unlikely that the remaining subscales (the Withdrawal scale, the Anxiety/Depression scale), would discriminate schizophrenic patients from patients with other diagnoses, in particular mood and anxiety disorders. Patients with schizophrenia spectrum diagnoses (F20 F29.99) were expected to score lower on the GAF and GAS scales. Patients with mood disorders (F30 F39.99) or schizoaffective disorders of depressive type (F25.1) were expected to score higher on the BDI scale. Patients with mood disorders (F30 F39.99) or schizoaffective disorders of depressive type (F25.1) were expected to score higher on the BPRS AD scale. Scales would be stable with regard to rank-order over the course of treatment. Temporal stability for all scales would be reduced in subjects scoring higher on the TD scale, owing to difficulty in assessing other psychopathology in patients with more positive symptoms. We intended to perform similar analyses for anxiety and manic states, but due to the near-absence of these disorders in the material, we decided to drop them Statistical analyses The Area Under the Curve (AUC) is a prevalence-independent and cut-score-independent measure of the degree to which a scale can discriminate between populations that has recently been recommended in the clinical psychology literature (Hsu, 2002). Given distributions of scores for a disordered and a non-
5 296 J. Lykke et al. / Addictive Behaviors 33 (2008) disordered population, the AUC reflects the probability that a randomly selected person from one population will have a scale score that exceeds that of a randomly selected person from the other population. The AUC can achieve values between 0 and 1.0. For a scale that does not discriminate at all between a disordered and a non-disordered population, the AUC is As the area increases, the discrimination between the two populations increases as well. Moderator regression was used to assess whether scales were less stable for patients with higher thought disorder severity. In moderator regression, the proposed predictor (in this case, the baseline value of a scale) and the proposed moderator (in this case, either abstinence status at discharge or the TD scale at baseline) are entered in the first step into the regression equation for the dependent variable (in this case, the respective scale at follow-up). In the second step, the interaction between the two is entered (i.e. the interaction between baseline scale and TD or abstinence status). If the interaction is significant in the second step, it would indicate that the relationship between the predictor and dependent variable varies over levels of the moderator variable (Tellegen, 1988). The analyses were conducted on SPSS for Windows, (SPSS, 2002). The purpose of the moderator regressions was to test whether thought disorder at baseline influenced the rank-order stability (measured as the test retest correlation) of measures. 3. Results 3.1. Sample description Of all 165 patients consecutively admitted in the period, 19 could not be included, either because they refused consent, or were unable to participate due to cognitive problems, or language problems. Two participants had missing data, leaving a sample of 144 patients for the convergent validity analysis. The cohort consisted of 66% males, and the mean age of patients was 40.8 years (SD=9.8, range: 20 65). The non-substance psychiatric diagnoses were 65% schizophrenia and related disorders (F20.9 F29.9), 24% mood disorders (F32.0 F39.9), 10% bipolar (F30.0 F32.9). Only 7.6% had an anxiety (F40 F50) diagnosis. Diagnoses for more than one class of substances were given to 76% (mean number of substance use diagnoses: 1.9, range: 0 4). The most common diagnosis was alcohol (65%), cannabis (36%), opioids (20%), and poly-substance dependence (19%). A total of 97% received 1 non-substance related psychiatric diagnosis, and 15% received 2 or 3 diagnoses. Data on all the BPRS and the GAF and GAS were available on 101 patients at both intake and discharge, and BAI and BDI were available on 85 at both intake and discharge. The mean baseline value on the BPRS was 25.8, corresponding to being borderline mildly ill for schizophrenic patients (Leucht et al., 2005), with a range from 7 to 64. The mean score on the GAF was 39.5 and for GAS was The mean scores for the BDI was 23.8 and the BAI was 20.8, corresponding to respectively moderate depression and moderate anxiety Discrimination between diagnostic groups The results of the area under the ROC curve analyses are shown in Table 1. Patients with schizophrenia spectrum disorders (e.g., schizophrenia, schizotypal disorder, schizoaffective disorder) could be discriminated by elevated TD, HS and full-scale BPRS, and GAF and GAS from other patients. No differences were found for self-report scales, or the remaining BPRS scales. For mood disorders, patients with diagnoses scored significantly higher on the BDI, the BPRS AD scale, and significantly lower on the BPRS TD, HS and A scales. No scales discriminated between
6 J. Lykke et al. / Addictive Behaviors 33 (2008) Table 1 Instruments' ability to discriminate between cases and controls at baseline Test result variable(s) Mean DX Mean DX+ Area under the curve Std. error a Asymptotic significance b Schizophrenia spectrum: F20 F29.99 N = 51 N = 93 BDI BAI GAS GAF BP TD W AD HS A Mood: F31.99 F39.99 and F25.10 N = 111 N = 34 BDI BAI GAS GAF BP TD W AD HS A Notes: BDI: Beck Depression Inventory. BAI: Beck Anxiety Inventory. BP: BPRS full scale. TD: Thought Disorder. W: Withdrawal. AD: Anxiety/Depression. HS: Hostility. A: Activity. a Under the non-parametric assumption. b Null hypothesis: true area =0.5. Area Under the Curve values theoretically believed to discriminate between groups are underlined, AUC values significant at p b 0.01 are in boldface. Mean DX+: Mean value of patients given the diagnosis. Mean DX : Mean value of patients without diagnosis. patients with vs. without anxiety. However, although the BAI has previously been found to discriminate well between patients with vs. without anxiety disorder (Kabacoff et al., 1997), the BAI correlates highly with measures of depression, and are often elevated in patients with depression (Steer & Ranieri, 1993), Table 2 Pearson inter-correlations of instruments from baseline to follow-up Follow-up BDI BAI BP TD W AD HS A Baseline BDI BAI BP TD W AD HS A Notes: Test retest correlations are italicized. Correlations that are statistically significant at p b 0.01 are in boldface.
7 298 J. Lykke et al. / Addictive Behaviors 33 (2008) Table 3 Moderator regression Thought disorder Beta T Sig. BDI BAI W AD HS A Note: Coefficients that are statistically significant at p b 0.01 are in boldface. and the AD scale explicitly measures both anxiety and depression. Thus, the failure of the BAI and the AD scale to discriminate between anxious patients and other patients, could be an artefact of the presence of patients with mood disorders in the sample. Therefore, we repeated the above analyses, excluding patients with mood disorders. This did not change the results, and neither the AD scale nor the BAI discriminated anxious patients from non-anxious (results not shown) Rank-order stability A total of 101 patients (78% of the patients who had agreed to participate in the study) completed the BDI and the BAI, were administered the BPRS at discharge. The test retest correlations from intake to discharge are shown in Table 2. The Pearson correlations are reported. We also analyzed the nonparametric Spearman correlations, but as the results did not differ, we decided to report the Pearson correlations. BDI, BAI, BP, TD, and W were all significantly correlated over the observation period. AD, HS and A were not strongly correlated. For those scales where the correlations were moderate (rn0.4), we calculated discriminant correlations, i.e., correlations between the same scale measured at different points in time, and correlations between unrelated constructs. The number of discriminant correlations for each scale was 25. For TD and W there were no discriminant correlations that were higher than the test retest correlations. For the BDI there were 3 discriminant violations, corresponding to 12% of possible. For the BAI, there was one discriminant violation. All discriminant violations for the BDI and the BAI were between the BDI and the BAI The influence of thought disorder on temporal stability We assessed the influence of thought disorder on the temporal stability of other scales. The results of the moderator regression analyses are shown in Table 3. Thought disorder had an influence on the temporal stability of the BAI and the A scale of the BPRS. In both cases, patients with higher thought disorder tended to show higher stability on the BAI and the A scale. 4. Discussion The main finding from this study was that the BPRS TD scale and full scale, and the Beck Depression Inventory were able to discriminate between relevant clinical groups. Also, TD, W BDI and BAI were
8 J. Lykke et al. / Addictive Behaviors 33 (2008) substantially correlated over the course of the study, and these correlations generally exceeded discriminant correlations. Thus, in spite of substantial co-morbidity in this sample, including symptoms that are likely to be substance-induced, some scales of the BPRS and the BDI clearly measure reliable symptoms with indication of discriminant validity. None of the hypotheses concerning the negative influence of thought disorder on the temporal stability of scales were supported. In contrast, two scales, the BAI and the BPRS-A scale, were more correlated at higher levels of thought disorder. Since our stated hypothesis was not supported in this respect, we can conclude, that symptoms are measured with no less reliability in severely ill psychotic patients, compared with less ill patients. Thus, several of the BPRS scales and the BDI passed tests as both reliable and valid measures of psychopathology. However, the withdrawal scale could not discriminate the patient group with schizophrenia from other patients. This may indicate that patients with co-morbid other psychopathology and substance use disorder are more difficult to discriminate from patients with co-morbid substance use disorder and schizophrenia with regard to negative symptoms. However, it may also indicate that the BPRS W scale is not an optimal measure of negative symptoms in schizophrenia. A strength of the study is the use of independent raters of psychopathology against diagnoses made based on a clinical intake interview. However, a limitation of the study was that no semi-structured interview was used in the diagnosis of psychopathology. The impact of this limitation is to make the discriminant validity findings of this study a lower bound of the actual discriminant validity of the instruments used. It is likely that the low prevalence of anxiety and bipolar disorders observed in this cohort would have been much higher, had a structured assessment of diagnoses been used. When a structured interview is used for the diagnosis of mental disorders, co-morbidity of anxiety disorders in substance abusers is sometimes much higher than what we observed in this study (Verthein et al., 2005). Another limitation is that the study did not include patients that were very acutely psychotic, with 75% of patients with F2X diagnoses scoring below 36, corresponding to only being mildly moderately ill for schizophrenia (Leucht et al., 2005). This limitation may impact the findings in two ways: first, it may reduce the observed differences between schizophrenic and non-schizophrenic patients on relevant indicators, such as the TD, W and HS scale. Secondly, it may reduce the impact of thought disorder on the stability of other scales. Had there been more acutely psychotic patients in the sample, we would probably have found some limitations in the long-term stability of measures at extreme levels of thought disturbance. In conclusion the measures BPRS full scale, Thought Disorders factor and BDI could be reliably used in a dual diagnosis sample. The hypothesis regarding the use of the BAI and its ability to discriminate between patient with and without anxiety disorders was not supported, although the low base rate of patients with anxiety disorders may have confounded this analysis. Whilst these results are promising further studies with larger samples of dual diagnosis patients need to be conducted to determine the reliability and validity of these and other instruments within this diagnostic group. Acknowledgements This research was supported by the Ministry of the Interior and Health Psychiatry Support Pool. The Scientific Ethical Committees at Copenhagen and Frederiksberg Municipalities evaluated the protocol and approved the study, Project # (KF) /03.
9 300 J. Lykke et al. / Addictive Behaviors 33 (2008) References APA. (2000). Diagnostic and statistical manual of mental disorders. Text revision (4th ed.). Washington D. C.: American Psychiatric Association. Beck, A. T., & Steer, R. A. (1991). Relationship between the Beck Anxiety Inventory and the Hamilton Anxiety Rating Scale with anxious outpatients. Journal of Anxiety Disorders, 5, Beck, A. T., Steer, R. A., & Garbin, M. G. (1988). Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review, 8, Elbogen, E. B., Swanson, J. W., Swartz, M. S., & Van Dorn, R. (2005). Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability. Journal of Nervous and Mental Disease, 193(10), Fuciec, M., Mohr, S., & Garin, C. (2003). Factors and motives associated with drop-out in an ambulatory service for patients with psychotic disorders. European Psychiatry, 18(4), Grant, B. F., Stinson, F. S., Hasin, D. S., Dawson, D. A., Chou, S. P., Dufour, M. C., et al. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61(8), Hedlund, J. L., & Vieweg, B. W. (1980). The Brief Psychiatric Rating Scale (BPRS): A comprehensive review. Journal of Operational Psychiatry, 11, Hesse, M. (2006). The Beck Depression Inventory in patients undergoing opiate agonist maintenance treatment. British Journal of Clinical Psychology, 45(Pt 3), Hsu, L. M. (2002). Diagnostic validity statistics and the MCMI III. Psychological Assessment, 14(4), Husband, S. D., Marlowe, D. B., Lamb, R. J., Iguchi, M. Y., Bux, D. A., Kirby, K. C., et al. (1996). Decline in self-reported dysphoria after treatment entry in inner-city cocaine addicts. Journal of Consulting and Clinical Psychology, 64(1), Kabacoff, R. I., Segal, D. L., Hersen, M., & Van Hasselt, V. B. (1997). Psychometric properties and diagnostic utility of the Beck Anxiety Inventory and the State-Trait Anxiety Inventory with older adult psychiatric outpatients. Journal of Anxiety Disorders, 11(1), Krystal, J. H., D'Souza, D. C., Gallinat, J., Driesen, N., & Abi-Dargham, A. (2006). The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia. Neurotoxicology Research, 10(3 4), Leucht, S., Kane, J. M., Kissling, W., Hamann, J., Etschel, E., & Engel, R. (2005). Clinical implications of Brief Psychiatric Rating Scale scores. British Journal of Psychiatry, 187, Mueser, K. T., Drake, R. E., & Wallach, M. A. (1998). Dual diagnosis a review of etiological theories. Addictive Behaviors, 23(6), Overall, J. E., & Gorham, D. R. (1988). The brief psychiatric rating scale: Recent developments in ascertainment and scaling. Psychopharmacological Bulletin, 24, Pedersen, G., Hagtvet, K. A., & Karterud, S. (2007). Generalizability studies of the global assessment of functioning-split version. Comprehensive Psychiatry, 48(1), Schuckit, M. A. (2006). Comorbidity between substance use disorders and psychiatric conditions. Addiction, 101(Suppl. 1), SPSS. (2002). SPSS for Windows. Chicago: SPSS Inc. Steer, R. A., & Ranieri, W. F. (1993). Further evidence for the validity of the Beck Anxiety Inventory with psychiatric outpatients. Journal of Anxiety Disorders, 7, Sumnall, H. R., Wagstaff, G. F., & Cole, J. C. (2004). Self-reported psychopathology in polydrug users. Journal of Psychopharmacology, 18(1), Tellegen, A. (1988). The analysis of consistency in personality assessment. Journal of Personality, 56, Thornicroft, G., Tansella, M., Becker, T., Knapp, M., Leese, M., Schene, A., et al. (2004). The personal impact of schizophrenia in Europe. Schizophrenia Research, 69(2 3), Verthein, U., Degkwitz, P., Haasen, C., & Krausz, M. (2005). Significance of comorbidity for the long-term course of opiate dependence. European Addiction Research, 11(1), WHO. (1993). The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research (10 ed.). Geneva: World Health Organization.
Psychiatric Comorbidity in Methamphetamine-Dependent Patients
Psychiatric Comorbidity in Methamphetamine-Dependent Patients Suzette Glasner-Edwards, Ph.D. UCLA Integrated Substance Abuse Programs August11 th, 2010 Overview Comorbidity in substance users Risk factors
More informationPHENOTYPE PROCESSING METHODS.
PHENOTYPE PROCESSING METHODS. We first applied exclusionary criteria, recoding diagnosed individuals as phenotype unknown in the presence of: all dementias, amnestic and cognitive disorders; unknown/unspecified
More informationPREVALENCE AND RISK FACTORS FOR PSYCHIATRIC COMORBIDITY IN PATIENTS WITH ALCOHOL DEPENDENCE SYNDROME Davis Manuel 1, Linus Francis 2, K. S.
PREVALENCE AND RISK FACTORS FOR PSYCHIATRIC COMORBIDITY IN PATIENTS WITH ALCOHOL DEPENDENCE SYNDROME Davis Manuel 1, Linus Francis 2, K. S. Shaji 3 HOW TO CITE THIS ARTICLE: Davis Manuel, Linus Francis,
More informationinformation for service providers Schizophrenia & Substance Use
information for service providers Schizophrenia & Substance Use Schizophrenia and Substance Use Index 2 2 3 5 6 7 8 9 How prevalent are substance use disorders among people with schizophrenia? How prevalent
More informationMental Health 101 for Criminal Justice Professionals David A. D Amora, M.S.
Mental Health 101 for Criminal Justice Professionals David A. D Amora, M.S. Director, National Initiatives, Council of State Governments Justice Center Today s Presentation The Behavioral Health System
More informationEFFECTIVENESS OF INPA TIENT TREATMENT PROGRAMS F OR DUALLY DIAGNOSED PAT IENTS.
FEDERAL SCIENCE POLICY. EFFECTIVENESS OF INPA TIENT TREATMENT PROGRAMS F OR DUALLY DIAGNOSED PAT IENTS. Promoter: Professor B. Sabbe (Universiteit Antwerpen). Researcher: B. De Wilde (Universiteit Antwerpen).
More informationPhenotype Processing Algorithm
Phenotype Processing Algorithm 1. Each individual has three associated variables which will be used for diagnostic classification. The variables are SZ, SA, and BS, which correspond to affection status
More informationUNDERSTANDING CO-OCCURRING DISORDERS. Frances A. Campbell MSN, PMH CNS-BC, CARN Michael Beatty, LCSW, NCGC-1 Bridge To Hope November 18, 2015
UNDERSTANDING CO-OCCURRING DISORDERS Frances A. Campbell MSN, PMH CNS-BC, CARN Michael Beatty, LCSW, NCGC-1 Bridge To Hope November 18, 2015 CO-OCCURRING DISORDERS What does it really mean CO-OCCURRING
More informationLEVEL I SA: OUTPATIENT INDIVIDUAL THERAPY - Adult
LEVEL I SA: OUTPATIENT INDIVIDUAL THERAPY - Adult Definition The following is based on the Adult Criteria of the Patient Placement Criteria for the Treatment of Substance-Related Disorders of the American
More informationPsychiatric Rehabilitation in the Community: A Program Evaluation of the
Psychiatric Rehabilitation in the Community: A Program Evaluation of the Community Transition Program at the Heather A Psychiatric Residential Rehabilitation Service Collaboratively Provided by: Community
More informationDEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource
E-Resource March, 2015 DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource Depression affects approximately 20% of the general population
More informationCLINICAL PRACTICE GUIDELINES Treatment of Schizophrenia
CLINICAL PRACTICE GUIDELINES Treatment of Schizophrenia V. Service Delivery Service Delivery and the Treatment System General Principles 1. All patients should have access to a comprehensive continuum
More informationDSM-5 and its use by chemical dependency professionals
+ DSM-5 and its use by chemical dependency professionals Greg Bauer Executive Director Alpine Recovery Services Inc. President Chemical Dependency Professionals Washington State (CDPWS) NAADAC 2014 Annual
More informationDual diagnosis: working together
Dual diagnosis: working together Tom Carnwath RCGP conference Birmingham 2007 DSM-IV & cocaine Cocaine intoxication Cocaine withdrawal Cocaine-induced sleep disorder Cocaine-induced sexual dysfunction
More informationICD- 9 Source Description ICD- 10 Source Description
291.0 Alcohol withdrawal delirium F10.121 Alcohol abuse with intoxication delirium 291.0 Alcohol withdrawal delirium F10.221 Alcohol dependence with intoxication delirium 291.0 Alcohol withdrawal delirium
More informationPreferred Practice Guidelines Bipolar Disorder in Children and Adolescents
These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder,
More informationCHAPTER 5 MENTAL, BEHAVIOR AND NEURODEVELOPMENT DISORDERS (F01-F99) March 2014. 2014 MVP Health Care, Inc.
CHAPTER 5 MENTAL, BEHAVIOR AND NEURODEVELOPMENT DISORDERS (F01-F99) March 2014 2014 MVP Health Care, Inc. CHAPTER 5 CHAPTER SPECIFIC CATEGORY CODE BLOCKS F01-F09 Mental disorders due to known physiological
More informationWORKERS COMPENSATION PROTOCOLS WHEN PRIMARY INJURY IS PSYCHIATRIC/PSYCHOLOGICAL
WORKERS COMPENSATION PROTOCOLS WHEN PRIMARY INJURY IS PSYCHIATRIC/PSYCHOLOGICAL General Guidelines for Treatment of Compensable Injuries Patient must have a diagnosed mental illness as defined by DSM-5
More informationThe Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Cardwell C Nuckols, PhD cnuckols@elitecorp1.com Cardwell C. Nuckols, PhD www.cnuckols.com SECTION I-BASICS DSM-5 Includes
More informationEXHIBIT D, COVERED BEHAVIORAL HEALTH DIAGNOSES
EXHIBIT D, COVERED BEHAVIORAL HEALTH DIAGNOSES Part I- Mental Health Covered Diagnoses 295-298.9 295 Schizophrenic s (the following fifth-digit sub-classification is for use with category 295) 0 unspecified
More informationSOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011
SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011 This document is intended to be used with the Somerset Dual Diagnosis Operational Working guide. This document provides principles governing joint working
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines - 2015
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More informationAddiction Billing. Kimber Debelak, CMC, CMOM, CMIS Director, Recovery Pathways
Addiction Billing Kimber Debelak, CMC, CMOM, CMIS Director, Recovery Pathways Objectives Provide overview of addiction billing contrasting E&M vs. behavioral health codes Present system changes in ICD-9
More informationSchizoaffective disorder
Schizoaffective disorder Dr.Varunee Mekareeya,M.D.,FRCPsychT Schizoaffective disorder is a psychiatric disorder that affects about 0.5 to 0.8 percent of the population. It is characterized by disordered
More informationClinical Perspective on Continuum of Care in Co-Occurring Addiction and Severe Mental Illness. Oleg D. Tarkovsky, MA, LCPC
Clinical Perspective on Continuum of Care in Co-Occurring Addiction and Severe Mental Illness Oleg D. Tarkovsky, MA, LCPC SAMHSA Definition Co-occurring disorders may include any combination of two or
More informationPOLL. Co-occurring Disorders: the chicken or the egg. Objectives
Co-occurring Disorders: the chicken or the egg Christopher W. Shea, MA, CRAT, CAC-AD Clinical Director Father Martin s Ashley Havre de Grace, Maryland chrismd104@yahoo.com Objectives To identify what is
More informationopiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380
opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 ed #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380 effects of alcohol in the brain 100 Top 30 698 heroin addiction 100
More informationObjectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons.
Addiction Psychiatry Program Site Specific Goals and Objectives Addiction Psychiatry (ADTU) Goal: By the end of the rotation fellow will acquire the knowledge, skills and attitudes required to recognize
More informationPsychological Correlates of Substance Abuse among First-admission. Patients with Substance Use Disorders
The International Journal of Indian Psychology ISSN 2348-5396 (e) ISSN: 2349-3429 (p) Volume 3, Issue 1, DIP: C00226V3I12015 http://www.ijip.in October December, 2015 Psychological Correlates of Substance
More informationWho We Serve Adults with severe and persistent mental illnesses such as schizophrenia, bipolar disorder and major depression.
We Serve Adults with severe and persistent mental illnesses such as schizophrenia, bipolar disorder and major depression. We Do Provide a comprehensive individually tailored group treatment program in
More informationFRN Research Report March 2011: Correlation between Patient Relapse and Mental Illness Post-Treatment
FRN Research Report March 2011: Correlation between Patient Relapse and Mental Illness Post-Treatment Background Studies show that more than 50% of patients who have been diagnosed with substance abuse
More informationDEPARTMENT OF PSYCHIATRY. 1153 Centre Street Boston, MA 02130
DEPARTMENT OF PSYCHIATRY 1153 Centre Street Boston, MA 02130 Who We Are Brigham and Women s Faulkner Hospital (BWFH) Department of Psychiatry is the largest clinical psychiatry site in the Brigham / Faulkner
More informationApplying ACT to Cases of Complex Depression: New Clinical and Research Perspectives
Applying ACT to Cases of Complex Depression: New Clinical and Research Perspectives Part I: Depression with Psychosis and Suicidality Brandon Gaudiano, Ph.D. Assistant Professor of Psychiatry Grant Support:
More informationComparison of Two Dual Diagnosis Tracks: Enhanced Dual Diagnosis versus Standard Dual Diagnosis Treatment Report Date: July 17, 2003
Comparison of Two Dual Diagnosis Tracks: Enhanced Dual Diagnosis versus Standard Dual Diagnosis Treatment Report Date: July 17, 2003 Objective: To compare treatment outcomes and treatment costs for four
More informationEmotional dysfunction in psychosis.
Early intervention Service Emotional dysfunction in psychosis. 2. Depression In First Episode Psychosis (DIPS) study: The role of awareness and appraisal Max Birchwood and Rachel Upthegrove Background:
More informationTopics In Addictions and Mental Health: Concurrent disorders and Community resources. Laurence Bosley, MD, FRCPC
Topics In Addictions and Mental Health: Concurrent disorders and Community resources Laurence Bosley, MD, FRCPC Overview Understanding concurrent disorders. Developing approaches to treatment Definitions
More informationhttp://www.elsevier.com/locate/permissionusematerial
This article was originally published in a journal published by Elsevier, and the attached copy is provided by Elsevier for the author s benefit and for the benefit of the author s institution, for non-commercial
More informationPresently, there are no means of preventing bipolar disorder. However, there are ways of preventing future episodes: 1
What is bipolar disorder? There are two main types of bipolar illness: bipolar I and bipolar II. In bipolar I, the symptoms include at least one lifetime episode of mania a period of unusually elevated
More informationPsychology Externship Program
Psychology Externship Program The Washington VA Medical Center (VAMC) is a state-of-the-art facility located in Washington, D.C., N.W., and is accredited by the Joint Commission on the Accreditation of
More informationMental Health Services
Mental Health Services At Maitland Private Hospital our team of professionals are committed to providing comprehensive assessment, treatment and support of people experiencing mental health issues. Located
More informationWashington State Regional Support Network (RSN)
Access to Care Standards 11/25/03 Eligibility Requirements for Authorization of Services for Medicaid Adults & Medicaid Older Adults Please note: The following standards reflect the most restrictive authorization
More informationAbnormal Psychology PSY-350-TE
Abnormal Psychology PSY-350-TE This TECEP tests the material usually taught in a one-semester course in abnormal psychology. It focuses on the causes of abnormality, the different forms of abnormal behavior,
More informationUniversity of Michigan Dearborn Graduate Psychology Assessment Program
University of Michigan Dearborn Graduate Psychology Assessment Program Graduate Clinical Health Psychology Program Goals 1 Psychotherapy Skills Acquisition: To train students in the skills and knowledge
More informationObservational study of the long-term efficacy of ibogaine-assisted therapy in participants with opioid addiction STUDY PROTOCOL
Observational study of the long-term efficacy of ibogaine-assisted therapy in participants with opioid addiction Purpose and Objectives STUDY PROTOCOL This research is an investigator-sponsored observational
More informationSupports for Professionals. and Mental Health Issues. Dublin, 28 th January 2010
Supports for Professionals working with Substance Abuse and Mental Health Issues Dublin, 28 th January 2010 Eoin Stephens MA, MIACP, MIAAAC President, PCI College Co-founder, Dual Diagnosis Ireland Supports
More informationAssessment and Diagnosis of DSM-5 Substance-Related Disorders
Assessment and Diagnosis of DSM-5 Substance-Related Disorders Jason H. King, PhD (listed on p. 914 of DSM-5 as a Collaborative Investigator) j.king@lecutah.com or 801-404-8733 www.lecutah.com D I S C L
More informationAre People with Serious Mental Illness Who Are Not Being Treated Dangerous?
Treatment Advocacy Center Backgrounder Are People with Serious Mental Illness Who Are Not Being Treated Dangerous? SUMMARY: (updated March 2014) 1. Most individuals with serious mental illnesses are not
More informationThe Quality Concern: Behavioral Health Inpatient Readmissions
The Readmissions Quality Collaborative Kick-Off Conference June 21, 2012 The Quality Concern: Behavioral Health Inpatient Readmissions Molly Finnerty, MD Director, Bureau of Evidence Based Services and
More informationDual Diagnosis in Older Adults: Implications for Services
Dual Diagnosis in Older Adults: Implications for Services Adam Searby Case Manager, Caulfield Hospital Mobile Aged Psychiatry Service PhD Candidate, RMIT University, Victoria, Australia Outline Dual diagnosis
More informationGAIN and DSM. Presentation Objectives. Using the GAIN Diagnostically
GAIN and DSM GAIN National Clinical Training Team 2011 Version 2 Materials Presentation Objectives Understand which DSM diagnoses are generated by GAIN ABS for the GAIN reports and which ones must be added
More informationMental Health Needs Assessment Personality Disorder Prevalence and models of care
Mental Health Needs Assessment Personality Disorder Prevalence and models of care Introduction and definitions Personality disorders are a complex group of conditions identified through how an individual
More informationFax # s for CAMH programs and services
INFORMATION AND INSTRUCTIONS STEP 1 BEFORE COMPLETING THE REFERRAL FORM CATS Program / General Psychiatry Memory Clinic, Geriatric Mental Health Program Go to www.camh.net for detailed information on each
More informationNew York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery
New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery USING THE 48 HOUR OBSERVATION BED USING THE 48 HOUR OBSERVATION BED Detoxification
More informationDSM-5: A Comprehensive Overview
1) The original DSM was published in a) 1942 b) 1952 c) 1962 d) 1972 DSM-5: A Comprehensive Overview 2) The DSM provides all the following EXCEPT a) Guidelines for the treatment of identified disorders
More informationConjoint Professor Brian Draper
Chronic Serious Mental Illness and Dementia Optimising Quality Care Psychiatry Conjoint Professor Brian Draper Academic Dept. for Old Age Psychiatry, Prince of Wales Hospital, Randwick Cognitive Course
More informationA comparison of two depressive symptomatology measures in residential substance abuse treatment clients
Journal of Substance Abuse Treatment 37 (2009) 318 325 Brief article A comparison of two depressive symptomatology measures in residential substance abuse treatment clients Kimberly A. Hepner, (Ph.D.),
More informationinformation for families Schizophrenia & Substance Use
information for families Schizophrenia & Substance Use Schizophrenia and Substance Use Index 2 3 5 6 7 8 9 10 Why do people with schizophrenia use drugs and alcohol? What is the impact of using substances
More informationMeasuring Addiction with DSM Criteria. May 20, 2014 Deborah Hasin, Ph.D. Columbia University
Measuring Addiction with DSM Criteria May 20, 2014 Columbia University Two Main Topics 1. DSM-5 definition of addiction and its empirical basis 2. PRISM-5 measure of DSM-5 addiction 2 DSM-IV Substance
More informationWorking with young people who have mental health and substance use issues. Samar Zakaria
Working with young people who have mental health and substance use issues. Samar Zakaria Main points Challenges faced while treating young adults in a dual diagnosis rehab unit Define dual diagnosis in
More informationTopics in Addictions and Mental Health: Concurrent Disorders and Community Resources. Christian G. Schütz MD PhD MPH
Topics in Addictions and Mental Health: Concurrent Disorders and Community Resources Christian G. Schütz MD PhD MPH Overview Introduction Epidemiology Treatment Principles and Issues Community Resources
More informationTHE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES
THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES PURPOSE: The goal of this document is to describe the
More informationDEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE
1 DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE ASSESSMENT/PROBLEM RECOGNITION 1. Did the staff and physician seek and document risk factors for depression and any history of depression? 2. Did staff
More information[KQ 804] FEBRUARY 2007 Sub. Code: 9105
[KQ 804] FEBRUARY 2007 Sub. Code: 9105 (Revised Regulations) Theory : Two hours and forty minutes Q.P. Code: 419105 Maximum : 100 marks Theory : 80 marks M.C.Q. : Twenty minutes M.C.Q. : 20 marks 1. A
More informationBehavioral Health Medical Necessity Criteria
Behavioral Health Medical Necessity Criteria Revised: 7/14/05 2 nd Revision: 9/14/06 3 rd Revision: 8/23/07 4 th Revision: 8/28/08; 11/20/08 5 th Revision: 8/27/09 Anthem Blue Cross and Blue Shield 2 Gannett
More informationQ&A. What Are Co-occurring Disorders?
What Are Co-occurring Disorders? Some people suffer from a psychiatric or mental health disorder (such as depression, an anxiety disorder, bipolar disorder, or a mood or adjustment disorder) along with
More informationA PROSPECTIVE EVALUATION OF THE RELATIONSHIP BETWEEN REASONS FOR DRINKING AND DSM-IV ALCOHOL-USE DISORDERS
Pergamon Addictive Behaviors, Vol. 23, No. 1, pp. 41 46, 1998 Copyright 1998 Elsevier Science Ltd Printed in the USA. All rights reserved 0306-4603/98 $19.00.00 PII S0306-4603(97)00015-4 A PROSPECTIVE
More informationIntroduction to the DSM-IV and Psychological Testing
Introduction to the DSM-IV and Psychological Testing Significance of Mental Illness In any given year, how many Americans will suffer with a diagnosable mental illness? How many will suffer with a serious
More informationPREDICTORS OF NON-EPILEPTIC SEIZURES IN AN INPATIENT EPILEPSY PROGRAM
PREDICTORS OF NON-EPILEPTIC SEIZURES IN AN INPATIENT EPILEPSY PROGRAM Robert C. Doss, PsyD John R. Gates, M.D This paper has been prepared specifically for: American Epilepsy Society Annual Meeting Philadelphia,
More informationDual Diagnosis in Addiction & Mental Health. users, family & friends
Dual Diagnosis in Addiction & Mental Health An introduction for Service users, family & friends You walk down the street and collapse. The hospital diagnoses a broken leg which is treated and fixed Yet
More informationCHAPTER 2: CLASSIFICATION AND ASSESSMENT IN CLINICAL PSYCHOLOGY KEY TERMS
CHAPTER 2: CLASSIFICATION AND ASSESSMENT IN CLINICAL PSYCHOLOGY KEY TERMS ABC chart An observation method that requires the observer to note what happens before the target behaviour occurs (A), what the
More informationCo-Occurring Disorders
Co-Occurring Disorders PACCT 2011 CAROLYN FRANZEN Learning Objectives List common examples of mental health problems associated with substance abuse disorders Describe risk factors that contribute to the
More informationThe Adverse Health Effects of Cannabis
The Adverse Health Effects of Cannabis Wayne Hall National Addiction Centre Kings College London and Centre for Youth Substance Abuse Research University of Queensland Assessing the Effects of Cannabis
More informationMcLean Ambulatory Treatment Center Adult Partial Hospital and Residential Program for Alcohol and Drug Abuse 115 Mill Street Belmont, MA 02478-9106
Program Description Staffed by highly experienced psychiatrists, psychologists, social workers, nurses and addiction specialists, we are committed to working collaboratively with referring providers. Program
More informationHow To Know If You Should Be Treated
Comprehensive ehavioral Care, Inc. delivery system that does not include sufficient alternatives to a particular LOC and a particular patient. Therefore, CompCare considers at least the following factors
More information309.28 F43.22 Adjustment disorder with mixed anxiety and depressed mood Adjustment disorder with disturbance of conduct
Description ICD-9-CM Code ICD-10-CM Code Adjustment reaction with adjustment disorder with depressed mood 309.0 F43.21 Adjustment disorder with depressed mood Adjustment disorder with anxiety 309.24 F43.22
More informationLEVEL II.1 SA: INTENSIVE OUTPATIENT - Adult
LEVEL II.1 SA: INTENSIVE OUTPATIENT - Adult Definition The following is based on the Adult Criteria of the Patient Placement Criteria for the Treatment of Substance- Related Disorders of the American Society
More informationAddictions. Assessment
Addictions Assessment What is Addiction?..a degree of involvement in a behaviour that can function both to produce pleasure and to provide relief from discomfort, to the point where the costs appear to
More informationFalling Between Two Stools. Dual Diagnosis: The need for multidisciplinary awareness and cooperation. Eoin Stephens
Falling Between Two Stools Dual Diagnosis: The need for multidisciplinary awareness and cooperation Eoin Stephens PCI College Dual Diagnosis Ireland www.pcicollege.ie www.dualdiagnosis.ie Dual Diagnosis
More informationBehavioral Health Best Practice Documentation
Behavioral Health Best Practice Documentation Click on the desired Diagnoses link or press Enter to view all information. Diagnoses: DSM-5 and ICD-10 Codes Major Depressive Disorder Bipolar Disorder Eating
More informationCo occuring Antisocial Personality Disorder and Substance Use Disorder: Treatment Interventions Joleen M. Haase
Co occuring Antisocial Personality Disorder and Substance Use Disorder: Treatment Interventions Joleen M. Haase Abstract: Substance abuse is highly prevalent among individuals with a personality disorder
More informationConcurrent Disorder Comprehensive Assessment: Every Interaction is an Intervention
Concurrent Disorder Comprehensive Assessment: Every Interaction is an Intervention Presented by: Kristin Falconer, Gillian Hutton & Stacey Whitman November 12, 2015 Disclosure Statement We have not received
More informationNorth Bay Regional Health Centre
Addictions and Mental Health Division Programs Central Intake Referral Form The Central Intake Referral Form is used in the District of Nipissing by the North Bay Regional Health Centre s Addictions and
More informationFactors Related To Psychiatric Hospitalization and Repeated Crisis Service Use By Dually- Diagnosed Persons
Factors Related To Psychiatric Hospitalization and Repeated Crisis Service Use By Dually- Diagnosed Persons Meeyoung Oh Min, Ph.D. Case Western Reserve University Cleveland, Ohio Statement of the Research
More informationAs the State Mental Health Authority, the office of Mental Health has two main functions:
NYSOMH Mission The mission of the New York State Office of Mental Health is to promote the mental health of all New Yorkers, with a particular focus on providing hope and recovery for adults with serious
More informationCo-Occurring Substance Use and Mental Health Disorders. Joy Chudzynski, PsyD UCLA Integrated Substance Abuse Programs
Co-Occurring Substance Use and Mental Health Disorders Joy Chudzynski, PsyD UCLA Integrated Substance Abuse Programs Introduction Overview of the evolving field of Co-Occurring Disorders Addiction and
More informationPerformance Standards
Performance Standards Outpatient Performance Standards are intended to provide a foundation and serve as a tool to promote continuous quality improvement and progression toward best practice performances,
More informationOutline. Drug and Alcohol Counseling 1 Module 1 Basics of Abuse & Addiction
Outline Drug and Alcohol Counseling 1 Module 1 Basics of Abuse & Addiction About Substance Abuse The Cost of Chemical Abuse/Addiction Society's Response The Continuum of Chemical Use Definitions of Terms
More informationMajor Depressive Disorder: Stage 1 Genomewide Association in Population-Based Samples.
Major Depressive Disorder: Stage 1 Genomewide Association in Population-Based Samples. Patrick Sullivan 1, Danyu Lin 1, Jung-Ying Tzeng 4, Gonneke Willemsen 2, Eco de Geus 2, Dorret Boomsma 2 Jan Smit
More informationExisting Student Learning Objectives Proposed Changes Feedback or Rationale to CACREP
CLINICAL MENTAL HEALTH COUNSELING Students who are preparing to specialize as clinical mental health counselors will demonstrate the knowledge, skills, and practices necessary to address a wide variety
More informationDEPRESSION CODING FACT SHEET FOR PRIMARY CARE CLINICIANS
DEPRESSION CODING FACT SHEET FOR PRIMARY CARE CLINICIANS Current Procedural Terminology (CPT ) (Procedure) Codes Initial assessment usually involves a lot of time determining the differential diagnosis,
More information3/17/2014. Pediatric Bipolar Disorder
Pediatric Bipolar Disorder 1 Highlighted Topics 1. Review the current DSM-5 definition and criteria for bipolar disorder 2. Highlight major historical developments in the scientific understanding of bipolar
More informationJournal of Psychiatric Intensive Care Vol.0 No.0:1 6 doi:10.1017/s1742646410000087 Ó NAPICU 2010. Original Article. Abstract.
Journal of Psychiatric Intensive Care Journal of Psychiatric Intensive Care Vol.0 No.0:1 6 doi:10.1017/s1742646410000087 Ó NAPICU 2010 Original Article Diagnosis after an acute psychiatric inpatient stay:
More information8 th Annual Addiction Day Conference & Networking Fair Scientific Program
8 th Annual Addiction Day Conference & Networking Fair Scientific Program Thank you for your interest in 8 th Annual Addiction Day & XXVI CSAM Scientific Conference. Please find an overview and learning
More informationTHE HYPOTHALAMIC-PITUITARY-GONADAL AXIS IN MALE PSYCHIATRIC INPATIENTS
THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS IN MALE PSYCHIATRIC INPATIENTS Bilyana Brdaroska A thesis submitted in accordance with the requirements for the admission to the degree of Doctor of Medicine of
More information1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136. Days and Hours: Monday Friday 8:30a.m. 6:00p.m. (305) 355 9028 (JMH, Downtown)
UNIVERSITY OF MIAMI, LEONARD M. MILLER SCHOOL OF MEDICINE CLINICAL NEUROPSYCHOLOGY UHEALTH PSYCHIATRY AT MENTAL HEALTH HOSPITAL CENTER 1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136 Days and Hours:
More informationCRITERIA CHECKLIST. Serious Mental Illness (SMI)
Serious Mental Illness (SMI) SMI determination is based on the age of the individual, functional impairment, duration of the disorder and the diagnoses. Adults must meet all of the following five criteria:
More information-- No equivalent DSM-IV code disorders 303 Alcohol dependence syndrome -- No equivalent DSM-IV code 303.9 [0-3]*
Substance Use Disorder Covered Diagnoses ICD-9 DSM-IV Alcohol Use Disorders 291 Alcohol-induced mental -- No equivalent DSM-IV code s 303 Alcohol syndrome -- No equivalent DSM-IV code 303.9 [0-3]* Other
More informationA Qualitative Examination of Co-occurring Disorders: Methamphetamine and Mental Illness. Executive Summary. Amber Ann Marinez, MSW
A Qualitative Examination of Co-occurring Disorders: Methamphetamine and Mental Illness Executive Summary By Amber Ann Marinez, MSW A project submitted in partial fulfillment of the requirements for the
More information- UNDERSTANDING - Dual Diagnosis
- UNDERSTANDING - Dual Diagnosis TABLE OF CONTENTS Introduction 3 The Link Between Mental Illness and Substance Abuse 4 Characteristics of an Effective Dual Diagnosis Treatment Plan 6 Dual Diagnosis Treatment
More informationWith Depression Without Depression 8.0% 1.8% Alcohol Disorder Drug Disorder Alcohol or Drug Disorder
Minnesota Adults with Co-Occurring Substance Use and Mental Health Disorders By Eunkyung Park, Ph.D. Performance Measurement and Quality Improvement May 2006 In Brief Approximately 16% of Minnesota adults
More information